Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Head and Neck Pathology
Published in: Head and Neck Pathology 1/2017

01-03-2017 | Original Paper

Update From the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumours of the Ear

Author: Lester D. R. Thompson

Published in: Head and Neck Pathology | Issue 1/2017

Login to get access

Abstract

The 2017 fourth edition of the World Health Organization Classification of Tumours, specifically as it relates to the ear (Chap. 9), has several changes. Importantly, the number of entities has been significantly reduced by omitting tumors or lesions if they do not occur exclusively or predominantly at this site or if they are discussed in detail elsewhere in the book. These entities include: embryonal rhabdomyosarcoma, osteoma, exostosis, angiolymphoid hyperplasia with eosinophilia, Schneiderian papilloma, inverted papilloma, lipoma of the internal auditory canal, hemangioma, hematolymphoid tumors, and secondary tumors. Paraganglioma was included in the neck chapter. New entries include otosclerosis and cholesteatoma, while refinements to nomenclature, classification and criteria were incorporated into the ceruminous gland tumors and epithelial tumors of the middle and inner ear. Specifically, the middle and inner ear were combined, as practical limitations of origin and imaging make a definitive separation artificial. The classification reflects the state of current understanding for these uncommon entities, with this update only highlighting selected entities that were the most significantly changed.
Literature
1.
Tumours of the Ear. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck, 4th ed. Lyon: IARC Press; 2017;261–73.
2.
Sandison A, Thompson LDR. Tumours of the external auditory canal: squamous cell carcinoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours, 4th ed. Lyon: IARC Press, 2017;263–64.
3.
Ouaz K, Robier A, Lescanne E, et al. Cancer of the external auditory canal. Eur Ann Otorhinolaryngol Head Neck Dis. 2013;130:175–82.CrossRefPubMed
4.
Johns ME, Headington JT. Squamous cell carcinoma of the external auditory canal. A clinicopathologic study of 20 cases. Arch Otolaryngol. 1974;100:45–9.CrossRefPubMed
5.
Wermker K, Kluwig J, Schipmann S, et al. Prediction score for lymph node metastasis from cutaneous squamous cell carcinoma of the external ear. Eur J Surg Oncol. 2015;41:128–35.CrossRefPubMed
6.
Shu MT, Lin HC, Lee JC, et al. Radiation-induced squamous cell carcinoma of the external auditory canal. Otol Neurotol. 2011;32:e24–e25.CrossRefPubMed
7.
Lo WC, Ting LL, Ko JY, et al. Malignancies of the ear in irradiated patients of nasopharyngeal carcinoma. Laryngoscope. 2008;118:2151–5.CrossRefPubMed
8.
Fleiner F, Jumah M, Goktas O. Cancer of the external auditory canal-diagnostic and treatment. Indian J Otolaryngol Head Neck Surg. 2009;61:270–4.CrossRefPubMed
9.
Miah MS, Crawford M, White SJ, et al. Malignant transformation from benign papillomatosis of the external auditory canal. Otol Neurotol. 2012;33:643–7.CrossRefPubMed
10.
Clark RR, Soutar DS, Hunter KD. A retrospective analysis of histological prognostic factors for the development of lymph node metastases from auricular squamous cell carcinoma. Histopathology. 2010;57:138–46.CrossRefPubMed
11.
Hosokawa S, Mizuta K, Takahashi G, et al. Carcinoma of the external auditory canal: histological and treatment groups. B-ENT. 2014;10:259–64.PubMed
12.
Repanos C, Mitchell D, Gandhi M, et al. Great auricular nerve perineural spread of squamous cell carcinoma. ANZ J Surg. 2012;82:179–80.CrossRefPubMed
13.
Mazzoni A, Danesi G, Zanoletti E. Primary squamous cell carcinoma of the external auditory canal: surgical treatment and long-term outcomes. Acta Otorhinolaryngol. 2014;34:129–37.
14.
Stafford ND, Frootko NJ. Verrucous carcinoma in the external auditory canal. Am J Otol. 1986;7:443–5.PubMed
15.
Sandison A, Thompson LDR. Tumours of the external auditory canal: Ceruminous adenoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. WHO classification of head and neck tumours, 4th ed. Lyon: IARC Press, 2017;265.
16.
Sandison A, Stenman G, Thompson LDR. Tumours of the external auditory canal: Ceruminous adenocarcinoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. WHO Classification of Head and Neck Tumours, 4th ed. Lyon: IARC Press, 2017;264.
17.
Crain N, Nelson BL, Barnes EL, et al. Ceruminous gland carcinomas: a clinicopathologic and immunophenotypic study of 17 cases. Head Neck Pathol. 2009;3:1–17.CrossRefPubMed
18.
Dehner LP, Chen KT. Primary tumors of the external and middle ear. Benign and malignant glandular neoplasms. Arch Otolaryngol. 1980;106:13–9.CrossRefPubMed
19.
Mansour P, George MK, Pahor AL. Ceruminous gland tumours: a reappraisal. J Laryngol Otol. 1992;106:727–32.CrossRefPubMed
20.
Jan JC, Wang CP, Kwan PC, et al. Ceruminous adenocarcinoma with extensive parotid, cervical, and distant metastases: case report and review of literature. Arch Otolaryngol Head Neck Surg. 2008;134:663–6.CrossRefPubMed
21.
Perzin KH, Gullane P, Conley J. Adenoid cystic carcinoma involving the external auditory canal. A clinicopathologic study of 16 cases. Cancer. 1982;50:2873–83.CrossRefPubMed
22.
Lott Limbach AA, Hoschar AP, Thompson LD, et al. Middle ear adenomas stain for two cell populations and lack myoepithelial cell differentiation. Head Neck Pathol. 2012;6:345–53.CrossRefPubMedPubMedCentral
23.
Ito K, Ito T, Tsukuda M, et al. An immunohistochemical study of adenoid cystic carcinoma of the external auditory canal. Eur Arch Otorhinolaryngol. 1993;250:240–4.CrossRefPubMed
24.
Thompson LD, Nelson BL, Barnes EL. Ceruminous adenomas: a clinicopathologic study of 41 cases with a review of the literature. Am J Surg Pathol. 2004;28:308–18.CrossRefPubMed
25.
Cankar V, Crowley H. Tumors Of ceruminous glands: a clinicopathological study Of 7 cases. Cancer. 1964;17:67–75.CrossRefPubMed
26.
27.
28.
Sandison A. Tumours of the middle and inner ear: aggressive papillary tumour. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. WHO classification of head and neck tumours, 4th ed. Lyon: IARC Press, 2017;266–67.
29.
Duderstadt M, Forster C, Welkoborsky HJ, et al. Adenomatous tumors of the middle ear and temporal bone: clinical, morphological and tumor biological characteristics of challenging neoplastic lesions. Eur Arch Otorhinolaryngol. 2012;269:823–31.CrossRefPubMed
30.
Tysome JR, Harcourt J, Patel MC, et al. Aggressive papillary tumor of the middle ear: a true entity or an endolymphatic sac neoplasm? Ear Nose Throat J. 2008;87:378–93.PubMed
31.
Siedentop KH, Jeantet C. Primary adenocarcinoma of the middle ear. Report of three cases. Ann Otol Rhinol Laryngol. 1961;70:719–33.CrossRefPubMed
32.
Dadas B, Alkan S, Turgut S, et al. Primary papillary adenocarcinoma confined to the middle ear and mastoid. Eur Arch Otorhinolaryngol. 2001;258:93–5.CrossRefPubMed
33.
Polinsky MN, Brunberg JA, McKeever PE, et al. Aggressive papillary middle ear tumors: a report of two cases with review of the literature. Neurosurgery. 1994;35:493–7.CrossRefPubMed
34.
Gaffey MJ, Mills SE, Fechner RE, et al. Aggressive papillary middle-ear tumor. A clinicopathologic entity distinct from middle-ear adenoma. Am J Surg Pathol. 1988;12:790–7.CrossRefPubMed
35.
Goebel JA, Smith PG, Kemink JL, et al. Primary adenocarcinoma of the temporal bone mimicking paragangliomas: radiographic and clinical recognition. Otolaryngol Head Neck Surg. 1987;96:231–8.PubMed
36.
Muller M, Zammit-Maempel I, Hill J, et al. An unusual middle-ear mass. J Laryngol Otol. 2010;124:108–10.CrossRefPubMed
37.
Kawabata S, Hollander MC, Munasinghe JP, et al. Epidermal growth factor receptor as a novel molecular target for aggressive papillary tumors in the middle ear and temporal bone. Oncotarget. 2015;6:11357–68.CrossRefPubMedPubMedCentral
38.
Sandison A. Tumours of the middle and inner ear: endolymphatic sac tumour. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. WHO classification of head and neck tumours, 4th ed. Lyon: IARC Press, 2017; 267–68.
39.
40.
Heffner DK. Low-grade adenocarcinoma of probable endolymphatic sac origin A clinicopathologic study of 20 cases. Cancer. 1989;64:2292–302.CrossRefPubMed
41.
Manski TJ, Heffner DK, Glenn GM, et al. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA. 1997;277:1461–6.CrossRefPubMed
42.
Megerian CA, Haynes DS, Poe DS, et al. Hearing preservation surgery for small endolymphatic sac tumors in patients with von Hippel-Lindau syndrome. Otol Neurotol. 2002;23:378–87.CrossRefPubMed
43.
Kupferman ME, Bigelow DC, Carpentieri DF, et al. Endolymphatic sac tumor in a 4-year-old boy. Otol Neurotol. 2004;25:782–6.CrossRefPubMed
44.
Skalova A, Sima R, Bohus P, et al. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): report of two cases with analysis of the VHL gene. Pathol Res Pract. 2008;204:599–606.CrossRefPubMed
45.
Lonser RR, Kim HJ, Butman JA, et al. Tumors of the endolymphatic sac in von Hippel-Lindau disease. NEngl J Med. 2004;350:2481–6.CrossRef
46.
Sandison A. Tumours of the middle and inner ear: otosclerosis. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. WHO classification of head and neck tumours, 4th ed. Lyon: IARC Press, 2017;268–69.
47.
Bittermann AJ, Wegner I, Noordman BJ, et al. An introduction of genetics in otosclerosis: a systematic review. Otolaryngol Head Neck Surg. 2014;150:34–9.CrossRefPubMed
48.
Karosi T, Sziklai I. Etiopathogenesis of otosclerosis. Eur Arch Otorhinolaryngol. 2010;267:1337–49.CrossRefPubMed
49.
Michaels L, Soucek S. Atypical mature bone in the otosclerotic otic capsule as the differentiated zone of an invasive osseous neoplasm. Acta Otolaryngol. 2014;134:118–23.CrossRefPubMed
50.
Rudic M, Keogh I, Wagner R, et al. The pathophysiology of otosclerosis: review of current research. Hear Res. 2015;330:51–6.CrossRefPubMed
51.
Declau F, van SM, Timmermans JP, et al. Prevalence of otosclerosis in an unselected series of temporal bones. Otol Neurotol. 2001;22:596–602.CrossRefPubMed
52.
Declau F, van SM, Timmermans JP, et al. Prevalence of histologic otosclerosis: an unbiased temporal bone study in Caucasians. Adv Otorhinolaryngol. 2007;65:6–16.PubMed
53.
54.
Carvalho B, Hamerschmidt R, Telles JE, et al. Anatomopathology of the superstructure of the stapes in patients with otosclerosis. Int Arch Otorhinolaryngol. 2015;19:1–4.CrossRefPubMed
55.
Sandison A. Tumours of the middle and inner ear: cholesteatoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. WHO classification of head and neck tumours, 4th ed. Lyon: IARC Press, 2017;269–70.
56.
Michaels L. Biology of cholesteatoma. Otolaryngol Clin N.Am. 1989;22:869–81.
57.
Michaels L. Origin of congenital cholesteatoma from a normally occurring epidermoid rest in the developing middle ear. Int J Pediatr Otorhinolaryngol. 1988;15:51–65.CrossRefPubMed
58.
Kuo CL, Shiao AS, Yung M, et al. Updates and knowledge gaps in cholesteatoma research. Biomed Res Int. 2015;2015:854024.PubMedPubMedCentral
59.
Kuo CL. Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research. Laryngoscope. 2015;125:234–40.CrossRefPubMed
60.
Nevoux J, Lenoir M, Roger G, et al. Childhood cholesteatoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2010;127:143–50.CrossRefPubMed
61.
Louw L. Acquired cholesteatoma pathogenesis: stepwise explanations. J Laryngol Otol. 2010;124:587–93.CrossRefPubMed
62.
Jindal M, Riskalla A, Jiang D, et al. A systematic review of diffusion-weighted magnetic resonance imaging in the assessment of postoperative cholesteatoma. Otol Neurotol. 2011;32:1243–9.CrossRefPubMed
63.
Heilbrun ME, Salzman KL, Glastonbury CM, et al. External auditory canal cholesteatoma: clinical and imaging spectrum. AJNR Am J Neuroradiol. 2003;24:751–6.PubMed
64.
65.
Torske KR, Thompson LD. Adenoma versus carcinoid tumor of the middle ear: a study of 48 cases and review of the literature. Mod Pathol. 2002;15:543–55.CrossRefPubMed
Metadata
Title
Update From the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumours of the Ear
Author
Lester D. R. Thompson
Publication date
01-03-2017
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 1/2017
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-017-0790-5

Other articles of this Issue 1/2017

Head and Neck Pathology 1/2017 Go to the issue

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Hematolymphoid Tumours

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Mucosal Melanomas

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Nasal Cavity, Paranasal Sinuses and Skull Base

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Oropharynx

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space